A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras
Authors
Keywords
Warfarin, Dabigatran, Rivaroxaban, Apixaban, Direct Oral Anticoagulant
Journal
DRUGS & AGING
Volume 33, Issue 6, Pages 427-436
Publisher
Springer Nature
Online
2016-05-06
DOI
10.1007/s40266-016-0369-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial
- (2015) Kuan H. Ng et al. AGE AND AGEING
- Factors Driving Anticoagulant Selection in Patients With Atrial Fibrillation in the United States
- (2015) Julie C. Lauffenburger et al. AMERICAN JOURNAL OF CARDIOLOGY
- Idarucizumab
- (2015) John W. Eikelboom et al. CIRCULATION
- The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation
- (2015) Victoria Jacobs et al. HEART RHYTHM
- Reasons for non-adherence to practice guidelines on stroke prevention in patients with atrial fibrillation: A cross-sectional study in primary care
- (2015) Sander van Doorn et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
- (2015) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of anticoagulant prescribing in non-valvular atrial fibrillation and development of a clinical tool for guiding anticoagulant selection
- (2015) Jennifer L. Garber et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
- (2015) Jonas Bjerring Olesen et al. THROMBOSIS AND HAEMOSTASIS
- Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
- (2015) Meijia Zhou et al. Journal of Managed Care & Specialty Pharmacy
- Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults
- (2015) Nathan James Pauly et al. Journal of Managed Care & Specialty Pharmacy
- Get With The Guidelines AFIB
- (2014) William R. Lewis et al.
- Pharmacology, benefits, unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation and proposal of a management algorithm
- (2014) Salvatore Rosanio et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism
- (2014) T. van der Hulle et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Therapy for Cancer-Related Thromboembolism
- (2014) Corinne Frere et al. SEMINARS IN ONCOLOGY
- Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism
- (2013) Soheir S. Adam et al. ANNALS OF INTERNAL MEDICINE
- Atrial fibrillation prevalence revisited
- (2013) L. Friberg et al. JOURNAL OF INTERNAL MEDICINE
- The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation
- (2013) Vanessa Roldán et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation
- (2013) G. Ntaios et al. NEUROLOGY
- Completeness of prescription information in US commercial claims databases
- (2013) Julie C. Lauffenburger et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models
- (2013) Brendan L. Limone et al. PLoS One
- National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011
- (2012) Kate Kirley et al.
- Comparative Efficacy and Safety of New Oral Anticoagulants in Patients With Atrial Fibrillation
- (2012) Sebastian Schneeweiss et al.
- Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?
- (2012) A. C. SPYROPOULOS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Guidelines on oral anticoagulation with warfarin - fourth edition
- (2011) David Keeling et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: A single-center, retrospective, observational study
- (2009) Laurie G. Jacobs et al. American Journal Geriatric Pharmacotherapy
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Atrial Fibrillation in Elderly Patients with Dementia
- (2008) Francesc Formiga et al. GERONTOLOGY
- The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients
- (2008) Mary E. Charlson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More